Beijing – August 2, 2021 – Cooley is a finalist for International Firm of the Year in the healthcare & life sciences, investment funds, and private equity & venture capital categories as part of China Law & Practice's annual awards. The event, which will take place in Beijing on September 15, identifies and honors the biggest and most important commercial legal matters involving lawyers and parties in China.
The distinctions complement Cooley's continued growth in Asia. The firm regularly advises Asia-based clients on unique business opportunities and legal challenges across the region, with strategically located offices in Shanghai, Beijing, Hong Kong and Singapore to handle the most complicated cross-border matters.
Cooley represents some of Asia's most innovative and dynamic technology and life sciences companies, advising on financings, corporate partnering and licensing, M&A, joint venture, capital markets and other strategic transactions. In addition, the firm has helped more than 100 fund managers in Asia form hundreds of venture capital and private equity funds. Cooley has been broadly recognized for its powerhouse technology, life sciences and venture capital practices, and has been named Healthcare & Life Sciences International Firm of the Year and Investment Funds International Firm of the Year by China Law & Practice in past years.